PDGFRB and glioblastoma: Additionally, as PDGFR has been shown to contribute to the pathogenesis of the proneural subtype of GBM, we hypothesize that tumors with elevated activity of this pathway may specifically benefit from TTFields and PDGFR inhibition [42].